Infliximab and adalimumab serum trough concentrations threshold associated with deep remission in inflammatory bowel disease

CONCLUSIONS: Trough IFX and ADA concentrations, CRP<5mg/L and FC<100 μg/g are associated with DR during maintenance therapy. Cutoff point of 3.1 and 6.3 g/mL for IFX and ADA respectively, were identified as DR predictors.PMID:34806581

Source: Farmacia Hospitalaria - November 22, 2021 Category: Drugs & Pharmacology Authors: Óscar Pascual-Marmaneu Mar ía D Belles-Medall Ra úl Ferrando-Piqueres Pedro Almela-Notari Mar ía Mendoza-Aguilera Tamara Álvarez-Martín Source Type: research